China Digest: Bamboocloud bags $44m; Lilly Asia leads $25m funding in ImmuneOnco

Bamboocloud has garnered 300 million yuan ($44 million) in a Series C round of financing from Sequoia Capital China and Kunlun Fund, while ImmuneOnco Biopharma has secured $25 million in a Series B round led by Lilly Asia Ventures.